Company Overview
Snapshot
Founded in August 2003 by Oren Sadiv, TeraGroup operates with 11–50 employees. The company has raised $91.5 million across four funding rounds. In March 2021, TeraGroup won the $6M XPRIZE Rapid COVID Testing competition for its Terahertz (THz) waves technology-based breath test.
Business overview
TeraGroup specializes in developing a terahertz platform for high-frequency and high-power chips and systems, primarily for semiconductor manufacturing. Originating from the Weizmann Institute of Science, the company focuses on technological advancements across various industries, including food, medical, pharmaceutical, and energy. Its core technology detects organic and inorganic materials in liquid and gaseous phases, providing previously unavailable scientific and commercial insights. TeraGroup also develops TeraWater, a uniquely processed water with enhanced properties for applications such as drug formulations, clean energy, and food preservation, often in collaboration with strategic industrial partners.
Strategic signal
In March 2021, TeraGroup won the $6M XPRIZE Rapid COVID Testing competition with its Terahertz (THz) waves technology-based breath test, the BioSafety test, which can determine COVID-19 negativity within 1-3 minutes. This achievement validates the company's core THz technology for rapid diagnostics and signals its potential to expand beyond its existing R&D partnerships into broader market applications for its diagnostic capabilities.
Log in to access full profile ›Company Intelligence Q&A
- What significant award did TeraGroup receive for its diagnostic technology?
- In March 2021, TeraGroup won the $6M XPRIZE Rapid COVID Testing competition for its BioSafety breath test, which uses Terahertz (THz) waves to detect COVID-19 negativity within 1-3 minutes.
- What was a key strategic partnership formed by TeraGroup in 2020?
- In August 2020, TeraGroup signed a strategic commercial agreement with APEX National Investment, an Emirati company, to collaborate on COVID-19 related research and development, including a testing device for the virus. This marked the first trade and economic partnership between Emirati and Israeli business sectors following diplomatic normalization.
- What is TeraGroup's total capital raised and number of funding rounds?
- TeraGroup has raised a total of $91.5 million across four funding rounds. One notable investment was from APEX National Investment in August 2020, which invested in TeraGroup's COVID-19 research.
- What is TeraGroup's core technological focus?
- TeraGroup focuses on developing a terahertz platform for high-frequency and high-power chips and systems, primarily for semiconductor manufacturing, and applies this technology to various industries for material detection and analysis.
- How does TeraGroup's technology address animal welfare in the egg industry?
- In October 2016, TeraGroup (then Novatrans) was involved in developing a method to determine the gender of a chicken egg before it hatches, aiming to prevent the culling of male chicks and offer a non-invasive solution for the egg industry.